Nancy Hanley Eriksson and Kevin Conroy received John S. McCain Leadership Awards from Translational Genomics Research Institute (TGen), part of City of Hope, at the institute’s 2024 Founders Dinner, an annual gathering held April 4 in Scottsdale, AZ.
Aleksandar Sekulic was named director of dermatology and director of translational research at City of Hope Cancer Center Phoenix. Sekulic was also hired as a professor in the Integrated Cancer Genomics Division at Translational Genomics Research Institute, also called TGen.
City of Hope established a mobile cancer prevention and screening program.
The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.
According to preclinical research published in Cell, researchers with City of Hope discovered that a type of human immune cells known to be important for allergy and other immune responses—human type 2 innate lymphoid cells, or ILC2s—can also attack cancer.
John Carpten, when he was named director of the City of Hope Comprehensive Cancer Center in April, took over a massive, newly formed national oncology network—the first of its kind.
Alan H. Bryce was named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope.
An international phase III clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of care when offered a combination treatment of KRAS inhibitor sotorasib and monoclonal antibody panitumumab.
Led by Lyor Cohen, global head of music at YouTube and Google, City of Hope raised more than $4.3 million at its Music, Film and Entertainment Industry fundraising group’s Spirit of Life gala.
Research from City of Hope and the Translational Genomics Research Institute, part of City of Hope, suggests that loss of a specific RNA molecule, miR-142, may lead to more aggressive forms of chronic myeloid leukemia.
